Advertisement
Frequency Therapeutics In... (FREQ)
NASDAQ: FREQ
· Real-Time Price · USD
0.30
0.01 (4.90%)
At close: Nov 03, 2023, 8:00 PM
4.90% (1D)
| Bid | n/a |
| Market Cap | 10.94M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -59.31M |
| EPS (ttm) | -1.9 |
| PE Ratio (ttm) | -0.1576842105263158 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 309,164 |
| Avg. Volume (20D) | 135,075 |
| Open | 0.29 |
| Previous Close | 0.29 |
| Day's Range | 0.28 - 0.32 |
| 52-Week Range | 0.18 - 5.59 |
| Beta | 0.77 |
About FREQ
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hea...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 3, 2019
Employees 46
Stock Exchange NASDAQ
Ticker Symbol FREQ
Website https://www.frequencytx.com